PROPANC BIOPHARMA NEW
$6.75
2
+$0+0% Friday 20:00
Statistics
Day High
5.75
Day Low
4.51
52W High
269.46
52W Low
2.76
Volume
139
Avg. Volume
264
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
14NovExpected
Expected EPS
N/A
Actual EPS
-0.0021
Financials
-Profit Margin
Unprofitable0Revenue
-2.01MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PPCBD. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
Show more...
CEO
Mr. James Nathanielsz
Employees
1
Country
US
Listings
0 Comments
Share your thoughts
FAQ
What is PROPANC BIOPHARMA NEW stock price today?▼
The current price of PPCBD is $6.75 USD — it has increased by +0% in the past 24 hours. Watch PROPANC BIOPHARMA NEW stock price performance more closely on the chart.
What is PROPANC BIOPHARMA NEW stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PROPANC BIOPHARMA NEW stocks are traded under the ticker PPCBD.
What were PROPANC BIOPHARMA NEW earnings last quarter?▼
PPCBD earnings for the last quarter are -0.71 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is PROPANC BIOPHARMA NEW revenue for the last year?▼
PROPANC BIOPHARMA NEW revenue for the last year amounts to 0 USD.
What is PROPANC BIOPHARMA NEW net income for the last year?▼
PPCBD net income for the last year is -2.01M USD.
How many employees does PROPANC BIOPHARMA NEW have?▼
As of April 01, 2026, the company has 1 employees.
When did PROPANC BIOPHARMA NEW complete a stock split?▼
The last stock split for PROPANC BIOPHARMA NEW was on January 29, 2025 with a ratio of 1:60000.
Where is PROPANC BIOPHARMA NEW headquartered?▼
PROPANC BIOPHARMA NEW is headquartered in Camberwell, US.